Cheminformatics Analysis of Organic Substituents: Identification of the Most Common Substituents, Calculation of Substituent Properties, and Automatic Identification of Drug-like Bioisosteric Groups
about
Synthetic Strategies for 5- and 6-Membered Ring Azaheterocycles Facilitated by Iminyl RadicalsMinimal Pharmacophoric Elements and Fragment Hopping, an Approach Directed at Molecular Diversity and Isozyme Selectivity. Design of Selective Neuronal Nitric Oxide Synthase InhibitorsEstimation of synthetic accessibility score of drug-like molecules based on molecular complexity and fragment contributionsThe Molecule Cloud - compact visualization of large collections of moleculesBIGCHEM: Challenges and Opportunities for Big Data Analysis in Chemistry227 Views of RNA: Is RNA Unique in Its Chemical Isomer Space?A new paradigm for designing ring construction strategies for green organic synthesis: implications for the discovery of multicomponent reactions to build molecules containing a single ringExploring chemical space for drug discovery using the chemical universe database.Molpher: a software framework for systematic chemical space explorationEstimation of the size of drug-like chemical space based on GDB-17 data.Lessons for fragment library design: analysis of output from multiple screening campaigns.Structure-based virtual ligand screening with LigandFit: pose prediction and enrichment of compound collections.Inverse molecular design in a tight-binding framework.Modification of S-Adenosyl-l-Homocysteine as Inhibitor of Nonstructural Protein 5 Methyltransferase Dengue Virus Through Molecular Docking and Molecular Dynamics Simulation.The rise of fragment-based drug discovery.A physicochemical descriptor-based scoring scheme for effective and rapid filtering of kinase-like chemical space.The discovery of potential acetylcholinesterase inhibitors: a combination of pharmacophore modeling, virtual screening, and molecular docking studies.Web-based cheminformatics and molecular property prediction tools supporting drug design and development at Novartis.Smooth heuristic optimization on a complex chemical subspace.Incorporating Virtual Reactions into a Logic-based Ligand-based Virtual Screening Method to Discover New LeadsIntegrated In Silico Fragment-Based Drug Design: Case Study with Allosteric Modulators on Metabotropic Glutamate Receptor 5.MolDIA: XML based system of molecular diversity analysis towards virtual screening and QSPR.Computational prediction of human drug metabolism.Chemistry and biology of multicomponent reactions.Graph-based similarity concepts in virtual screening.Chemical signals in terrestrial vertebrates: search for design features.Finding Chemical Structures Corresponding to a Set of Coordinates in Chemical Descriptor Space.Bioisosteric Replacement and Scaffold Hopping in Lead Generation and Optimization.Progress in the Visualization and Mining of Chemical and Target Spaces.Exploring experimental fitness landscapes for chemical synthesis and property optimization.Microwave-promoted synthesis of 3-amino-substituted 1,2-benzisoxazoles.Semiempirical quantum chemistry model for the lanthanides: RM1 (Recife Model 1) parameters for dysprosium, holmium and erbium.An algorithm to identify functional groups in organic molecules.Pushing the boundaries of intrinsically stable radicals: inverse design using the thiadiazinyl radical as a template.Bioavailability of veterinary drugs in vivo and in silico.Exploring chemical space with discrete, gradient, and hybrid optimization methods.A gradient-directed Monte Carlo approach to molecular design.Size estimation of chemical space: how big is it?Herman Skolnik award symposium honoring Yvonne Martin.Inverse design of molecules with optimal reactivity properties: acidity of 2-naphthol derivatives.
P2860
Q26746980-1ED14EA2-C3A9-4549-A124-A322BE2A93B0Q27649995-341A8C3E-7FB2-41E3-8C0E-404D4628F8FEQ27702095-CF82ED75-D7E7-40C3-93CD-B2EF01CC434CQ27768978-503E6E16-63AA-4190-A83C-1244E6056E46Q28591396-3AAD4252-05DB-4704-9B05-F6AF9742D0D2Q28645765-03F1AA66-068A-4F88-9071-837993EFE2CDQ28817207-E20AE0EA-CD33-4B98-BF4C-772AAB492CFAQ30485721-CB12DAC4-0D3A-42B0-9E04-382169A2544FQ30576905-FA25B0BF-41A5-4AE6-9435-84884CD52CDAQ30662631-3BDD0CBC-5762-4E06-8DF9-42B6878C4DA5Q30864260-BE4C57F5-305D-4D2C-AB8C-261D11D73884Q33285015-C836477D-9EC9-49C9-819E-10E60758230EQ33357810-3294AD94-381A-436E-9DD0-AFBE60946186Q33602883-FF892BD7-1B98-4747-92D7-E962C202EA30Q33838157-3506CA48-366F-43D2-BB9F-ED7B8DEC3FC2Q34153687-3EBB423B-29D9-4BE1-B339-09D75BB18975Q34564278-408B40ED-460D-409A-A58E-DE766CD6A4EBQ35647271-F76120CB-503C-4ADD-9554-BB41EFC60F31Q35761187-B2C5D8F6-6EED-46D5-95D4-4FA1ACCD89DAQ35846009-E86FDD04-BD9F-4BDC-9810-058C00A6B926Q36385771-B301DB4E-5654-4C79-A61C-5381E7AB5A09Q36412141-79894C36-2777-41E1-BBEA-78D780BFF9E3Q36572605-5D65E6A9-86C7-48DA-96F5-625E72EADF8FQ37017587-BE0E0910-B809-441D-A55D-37E1006B6EFFQ37859732-5242BAEC-72ED-464F-B9AA-2113F8B3BC31Q38534625-ECEDED09-621C-43C6-BE2E-70E6DF7E2744Q38827264-1CA61F08-C396-41BD-9536-97EE8E38877EQ38910044-91DF4A86-4A50-40C8-8834-3BCABF000FCAQ38915513-39F245D7-FF5E-4D5B-86D1-808E9228D2F4Q39003059-FC41CC7B-7062-47F6-A4A9-98C819307C0FQ39769157-9D6F01D7-4D47-4BB4-85E2-572F190B0094Q41904003-7A27E6A8-CE22-4D6D-8071-9C4E12D0BB68Q42931952-3292C837-4B15-46A0-80F6-5B6E4629A79EQ43165779-3E4E04E6-AC90-47FA-931A-C59C77209CAAQ45349568-2A2CCE23-3B1F-495D-AD86-27E29D8ED3C6Q46221532-81930CE0-60DE-41FA-A7E2-ADF282030EF9Q46420712-EC8BA9C2-6DF3-40DB-9B0D-4DE3FE73A29BQ47321477-4BD5A62B-5DB5-4D61-8FE0-BE02241B78D8Q48311195-7A7F45D6-FD6F-499F-B4B0-5976ACAE281CQ51599909-F87AFBE4-A14F-4B99-9A86-D68D06A8AE45
P2860
Cheminformatics Analysis of Organic Substituents: Identification of the Most Common Substituents, Calculation of Substituent Properties, and Automatic Identification of Drug-like Bioisosteric Groups
description
article
@en
im März 2003 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в березні 2003
@uk
ലേഖനം
@ml
name
Cheminformatics Analysis of Or ...... Drug-like Bioisosteric Groups
@en
Cheminformatics Analysis of Or ...... Drug-like Bioisosteric Groups
@nl
type
label
Cheminformatics Analysis of Or ...... Drug-like Bioisosteric Groups
@en
Cheminformatics Analysis of Or ...... Drug-like Bioisosteric Groups
@nl
prefLabel
Cheminformatics Analysis of Or ...... Drug-like Bioisosteric Groups
@en
Cheminformatics Analysis of Or ...... Drug-like Bioisosteric Groups
@nl
P356
P1476
Cheminformatics Analysis of Or ...... Drug-like Bioisosteric Groups
@en
P304
P356
10.1021/CI0255782
P50
P577
2003-03-01T00:00:00Z